bluebird bio gets FDA approval for Skysona to treat cerebral adrenoleukodystrophy
bluebird bio has received US Food and Drug Administration (FDA) Accelerated Approval for Skysona to treat active cerebral adrenoleukodystrophy (CALD). According to the firm, Skysona (elivaldogene autotemcel), also